Corneal sensitivity and tear function in neurodegenerative diseases

Current Eye Research

Volumn 40, Issue 4, 2015, Pages 423-428

  Örnek, Nurgül ^a   Daʇ, Ersel ^a   Örnek, Kemal ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Corneal sensitivity; Neurodegenerative diseases; Tear function

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA SENSIBILITY; DEGENERATIVE DISEASE; EPILEPSY; FEMALE; FRIEDREICH ATAXIA; FUNCTION TEST; HUMAN; LACRIMATION; LACRIMATION DISORDER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPHTHALMIC ESTHESIOMETER; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIRMER TEST; TEAR BREAK UP TIME; TIME; ADOLESCENT; COMPARATIVE STUDY; CORNEA; DRY EYE; LACRIMAL FLUID; LACRIMAL GLAND DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; VISUAL SYSTEM EXAMINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORNEA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; FEMALE; HUMANS; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PROSPECTIVE STUDIES; TEARS; YOUNG ADULT;

EID: 84925293077     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.930154     Document Type: Article

References (43)

1. Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ 2011;163:407-419.
2. Armstrong RA. Visual signs and symptoms of Parkinson's disease. Clin Exp Optom 2008;91:129-138.
3. Ceccaldi M. Vision in Alzheimer's disease. Rev Neurol (Paris) 1996;152:441-446.
4. Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 2011;31:362-373.
5. Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C, et al. Visual system involvement in patients with Friedreich's ataxia. Brain 2009;132:116-123.
6. Muranaka H, Fujita H, Goto A, Osari SI, Kimura Y. Visual symptoms in epilepsy and migraine: localization and patterns. Epilepsia 2001;42:62-66.
7. Pelak VS, Hall DA. Neuro-ophthalmic manifestations of neurodegenerative disease. Ophthalmol Clin North Am 2004;17:311-320.
8. Katz B, Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Surv Ophthalmol 1989;34:31-43.
9. Wolin MJ. Alzheimer's disease and the eye. J S C Med Assoc 1994;90:534-538.
10. Baker DR, Mendez MF, Townsend JC, Ilsen PF, Bright DC. Optometric management of patients with Alzheimer's disease. J Am Optom Assoc 1997;68:483-494.
11. Woodruff-Pak DS, Papka M, Romano S, Li YT. Eyeblink classical conditioning in Alzheimer's disease and cerebrovascular dementia. Neurobiol Aging 1996;17:505-512.
12. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 2005;16:315-320.
13. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 2011;26:2387-2395.
14. Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX. Ocular motor and sensory function in Parkinson's disease. Ophthalmology 2012;119:178-182.
15. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011;17:431-436.
16. Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye (Lond) 2012;26:315-320.
17. Hocking DR, Fielding J, Corben LA, Cremer PD, Millist L, White OB, et al. Ocular motor fixation deficits in Friedreich ataxia. Cerebellum 2010;9:411-418.
18. Abe T, Abe K, Aoki M, Itoyama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997;115:231-236.
19. Bajwa R, Jay WM, Asconapé J. Neuro-ophthalmologic manifestations of epilepsy. Semin Ophthalmol 2006;21:255-261.
20. Reddy VC, Patel SV, Hodge DO, Leavitt JA. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea 2013;32:631-635.
21. Tamer C, Melek IM, Duman T, Oksüz H. Tear film tests in Parkinson's disease patients. Ophthalmology 2005;112:1795.
22. Kwon OY, Kim SH, Kim JH, Kim MH, Ko MK. Schirmer test in Parkinson's disease. J Korean Med Sci 1994;9:239-242.
23. Miró J, Peña-Sagredo JL, Berciano J, Insúa S, Leno C, Velarde R. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol 1990;27:582-584.
24. Coyle PK, Sibony PA. Tear analysis in multiple sclerosis. Neurology 1986;36:547-550.
25. Annunziata P, De Santi L, Di Rezze S, Millefiorini E, Capello E, Mancardi G, et al. Clinical features of Sjogren's syndrome in patients with multiple sclerosis. Acta Neurol Scand 2011;124:109-114.
26. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65-74.
27. Wakamatsu TH, Dogru M, Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol 2008;71:72-79.
28. Bourcier T, Acosta MC, Borderie V, Borrás F, Gallar J, Bury T, et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci 2005;46:2341-2345.
29. Benítez-Del-Castillo JM, Acosta MC, Wassfi MA, Diáz-Valle D, Gegúndez JA, Fernandez C, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 2007;48:173-181.
30. Matsui H, Kumano Y, Zushi I, Yamada T, Matsui T, Nishida T. Corneal sensation after correction of myopia by photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2001;27:370-373.
31. Kumano Y, Matsui H, Zushi I, Mawatari A, Matsui T, Nishida T, et al. Recovery of corneal sensation after myopic correction by laser in situ keratomileusis with a nasal or superior hinge. J Cataract Refract Surg 2003;29:757-761.
32. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
33. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78:409-416.
34. Kahana E, Leibowitz U, Alter M. Brainstem and cranial nerve involvement in multiple sclerosis. Acta Neurol Scand 1973;49:269-279.
35. Zadro I, Barun B, Habek M, Brinar VV. Isolated cranial nerve palsies in multiple sclerosis. Clin Neurol Neurosurg 2008;110:886-888.
36. Palakuru JR, Wang J, Aquavella JV. Effect of blinking on tear dynamics. Invest Ophthalmol Vis Sci 2007;48:3032-3037.
37. Fisher A. Muscarinic receptor agonists in Alzheimer's disease. CNS Drugs 1999;12:197-214.
38. Gunal DI, Afsar N, Tanridag T, Aktan S. Autonomic dysfunction in multiple sclerosis: correlation with diseaserelated parameters. Eur Neurol 2002;48:1-5.
39. Chakravarty K, al-Jafari MS. Phenytoin-induced pseudo-Sjögren's syndrome. Br J Rheumatol 1996;35:1033-1034.
40. Marino D, Malandrini A, Rocchi R, Selvi E, Federico A. Transient "sicca syndrome"during phenobarbital treatment. J Neurol Sci 2011;15:164.
41. Ingall TJ, McLeod JG. Autonomic function in Friedreich's ataxia. J Neurol Neurosurg Psychiatry 1991;54:162-164.
42. Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol 2012;2012:1-8.
43. Murphy PJ, Lawrenson JG, Patel S, Marshall J. Reliability of the noncontact corneal aesthesiometer and its comparison with the Cochete Bonnet aesthesiometer. Ophthal Physiol Opt 1998;18:e532-e539.